Medicare Enrolled
Dr. Ilija Aleksic, M.D.
Urology Physician · Syracuse, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aleksic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aleksic?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aleksic
Dr. Ilija Aleksic is an urology physician in Syracuse, NY, with 12 years of NPI registration. Based on federal Medicare data, Dr. Aleksic performed 11,767 Medicare services across 1,640 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aleksic received a total of $16,486 from 51 pharmaceutical and/or device companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aleksic is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 7% volume in NY
$16,486 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,767
Medicare services
Top 7% in NY for urology physician
1,640
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~981 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
6,400 | $0 | $2 |
| BCG treatment for bladder cancer | 3,500 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
452 | $2 | $12 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
217 | $8 | $11 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
198 | $58 | $180 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $94 | $265 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
109 | $7 | $46 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
81 | $67 | $215 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
72 | $107 | $405 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
70 | $178 | $960 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
60 | $0 | $20 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
56 | $22 | $130 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
53 | $195 | $675 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
43 | $168 | $730 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
40 | $55 | $184 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
34 | $7 | $90 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $103 | $400 |
| Simple change of bladder tube | 28 | $73 | $222 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
26 | $48 | $153 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
24 | $76 | $271 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $80 | $265 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
19 | $19 | $45 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
17 | $12 | $206 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
12 | $193 | $506 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
12 | $114 | $273 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $70 | $183 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,486
Total received (2018-2024)
Avg $2,355/year across 7 years
Top 13% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
310
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,728 (77.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,758 (22.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,106
2023
$3,703
2022
$1,723
2021
$725
2020
$297
2019
$2,916
2018
$17
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ferring Pharmaceuticals Inc.
$1,895
Telix Pharmaceuticals
$1,863
COLOPLAST CORP
$866
Janssen Biotech, Inc.
$631
Axonics, Inc.
$450
Myriad Genetic Laboratories, Inc.
$225
Teleflex LLC
$220
Merck Sharp & Dohme LLC
$163
Astellas Pharma US Inc
$156
Sumitomo Pharma America, Inc.
$119
Calyxo, Inc.
$94
Novartis Pharmaceuticals Corporation
$60
Antares Pharma, Inc.
$59
Endo USA, Inc.
$57
SUN PHARMACEUTICAL INDUSTRIES INC.
$53
UROGEN PHARMA, INC.
$37
Tolmar, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$33
Olympus America Inc.
$28
Endo Pharmaceuticals Inc.
$23
Dendreon Pharmaceuticals LLC
$20
IMMUNITYBIO, INC.
$17
Top 3 companies account for 65.1% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$3,122
Ferring Pharmaceuticals Inc.
$1,931
Telix Pharmaceuticals
$1,897
Boston Scientific Corporation
$1,540
COLOPLAST CORP
$987
Teleflex LLC
$819
Janssen Biotech, Inc.
$748
Axonics, Inc.
$699
Astellas Pharma US Inc
$587
Myriad Genetic Laboratories, Inc.
$576
Palette Life Sciences, Inc.
$347
Merck Sharp & Dohme LLC
$281
UroGen Pharma, Inc.
$249
Sumitomo Pharma America, Inc.
$215
180 Medical, Inc.
$186
Dendreon Pharmaceuticals LLC
$176
Endo Pharmaceuticals Inc.
$174
TOLMAR Pharmaceuticals, Inc.
$161
UROVANT SCIENCES INC
$141
Bayer HealthCare Pharmaceuticals Inc.
$124
Antares Pharma, Inc.
$108
ACCORD HEALTHCARE, INC.
$106
PROCEPT BioRobotics Corporation
$101
Calyxo, Inc.
$94
DENTSPLY IH Inc.
$93
NeoTract Inc.
$90
SUN PHARMACEUTICAL INDUSTRIES INC.
$77
Olympus America Inc.
$67
Medtronic, Inc.
$63
Novartis Pharmaceuticals Corporation
$60
Endo USA, Inc.
$57
Myovant Sciences Inc.
$55
Tolmar, Inc.
$52
UROGEN PHARMA, INC.
$49
Amgen Inc.
$48
Accord Healthcare, Inc.
$40
PFIZER INC.
$36
AbbVie, Inc.
$36
AbbVie Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$33
Otsuka America Pharmaceutical, Inc.
$31
PALETTE LIFE SCIENCES, INC.
$30
Laborie Medical Technologies Corp.
$30
Agiliti Surgical, Inc.
$23
Foundation Medicine, Inc.
$22
Merck Sharp & Dohme Corporation
$18
KARL STORZ Endoscopy-America
$17
IMMUNITYBIO, INC.
$17
Clarus Therapeutics Inc.
$15
Verity Pharmaceuticals Inc.
$14
HealthTronics Mobile Solutions, LLC
$8
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS 700 · AMS 700 CXR RTE Kit · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Axonics · BOTOX · Bulkamid · CAMCEVI · CVAC ASPIRATION SYSTEM · Coloplast TFL Drive · ELIGARD · ERLEADA · GEMTESA · GENTLECATH · GENTLECATH GLIDE · General - Erectile Dysfunction · GentleCath · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LithoVue · LoFric · Lupron Depot · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · Porges Coloplast · Prolaris · Prolia · Sonablate · TACTRA · TITAN · TOVIAZ · Titan · Trelstar · URETERO-RENO-FIBERSCOPE FLEX-X · UROLIFT · UroLift · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
61
Per 100K population
12.9
County median income
$74,740
Nearest hospital
CROUSE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aleksic is a mixed practice specialist, with above-average Medicare volume (top 7% in NY), with low-engagement industry engagement in the top 13% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aleksic experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Aleksic performed 6,400 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aleksic receive payments from pharmaceutical companies?
Yes. Dr. Aleksic received a total of $16,486 from 51 companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aleksic's costs compare to other urology physicians in Syracuse?
Dr. Aleksic's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aleksic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Syracuse
Browse urology physicians in Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Ferring Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ferring Pharmaceuticals Inc.
By company
Telix Pharmaceuticals Payments to Doctors
See all physicians who received payments from Telix Pharmaceuticals.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology